Examination Report |
1 | General Power of Attorney | 24 Mar 2010 |
2 | Additional Representation Sheet | 02 Nov 2012 |
2 | TM-1 | 02 Nov 2012 |
3 | Additional Representation Sheet | 02 Nov 2012 |
3 | TM-1 | 02 Nov 2012 |
4 | Reply to Exam Report (MIS-R) | 14 Nov 2014 |
5 | Journal Copy | 12 Mar 2018 |
6 | Certificate | 21 May 2018 |
7 | TM-R(RENEWAL OF TRADE MARK) | 19 Oct 2022 |
1 | Dispatching of Examination Report for : 2421537 | 1575586 | 948027 | 04 Oct 2014 |
2 | Hearing Notice (Show Cause) | 1685508 | 982354 | 18 Nov 2014 |
3 | Hearing Notice (Adjourned) | 2158962 | 1180419 | 19 Jun 2015 |
4 | Hearing Notice (Show Cause) | 4517243 | 2021514 | 08 Feb 2017 |
5 | Hearing Notice (Adjourned) | 5397660 | 2302551 | 14 Nov 2017 |
6 | Tribunal ABA Notice for : 2421537 | 5593622 | 20 Dec 2017 | |
7 | O3 NOTICE | 13795916 | 5661780 | 15 Jul 2022 |
8 | RENEWAL INTIMATION LETTER | 14254324 | 23 Oct 2022 |
As per IP India data the trademark was applied on 02 November 2012.
STALLION LABORATORIES applied for Cipxacin.
Listed class of trademark Cipxacin is 5.
Cipxacin is on the Registered stage of the trademark process.
Serial Number provided to trademark application is 2421537
Trademark application was filed by the following attorney agent:
B. D. Shukla & Company
The trademark is categorized as DEVICE.